Your Best Partner in Designing Robust & Organ-targeted Oligonucleotide Drugs

Pushing Boundaries of ASO Druggabilities by Improving Potency and Optimizing Delivery

Rational Drug Design Based on Quantum Mechanics and Assisted by AI

Our Mission

Revolutionize Pharmaceutical Industry and Enhance Social Well-being by Greatly Reduce the Time and Cost of Oligonucleotide Drug R&D

Our vision

World-class Leading Power in Oligonucleotide Drug Development

❮ ❯

Platform & Pipeline

Focus on Delivery & Expanded Mechanisms of ASO, Breaking Through Undruggable Targets

xNA addresses the challenges of pharmacodynamics (PD) and pharmacokinetics (PK) associated with therapeutic oligonucleotides by offering novel solutions through target selection, rational chemical design, and data science. This approach expands the druggable boundaries of therapeutic oligonucleotides and resolves the most crucial issues in the field.

Learn More

About Us

Innovative Biotech Company Specializing in the Design and Development of Robust and Tissue-specific Antisense Oligonucleotides (ASO)

xNA Biotechnology Co., Ltd is an innovative biotech company specializing in the design and development of robust and tissue-specific therapeutic antisense oligonucleotides (ASO). Our cutting-edge approach leverages advanced quantum mechanics models and proprietary datasets, empowering us to deliver groundbreaking solutions.

Learn More

Platform & Pipeline

Focus on Delivery & Expanded Mechanisms of ASO, Breaking Through Undruggable Targets

About Us

Innovative Biotech Company Specializing in the Design and Development of Robust and Tissue-specific Antisense Oligonucleotides (ASO)

Contact